MedCity News August 20, 2020
Attaining reimbursement often has the greatest impact on patient access and can progress a new treatment toward widespread adoption.
What is the road to nationwide local Medicare coverage of a novel technology? It has to start with a medical milestone of course – FDA approval of an innovative treatment method. For certain, receiving this approval is a critical distinction and one that typically requires years dedicated to clinical research.
However, once a first-in-class treatment becomes available commercially what comes next for physicians and the patients they’re treating? Attaining reimbursement often has the greatest impact on patient access and can progress a new treatment toward widespread adoption.
While the benefits are far-reaching, the path from FDA approval to reimbursement can be...